PLC β2 Polyclonal Antibody

Rabbit Anti-PLC β2 Polyclonal Antibody

Product Specifications

Background

PLCB2 (Phospholipase C Beta 2) is a Protein Coding gene. Diseases associated with PLCB2 include prostate leiomyosarcoma. Among its related pathways are cGMP-PKG signaling pathway and African trypanosomiasis. GO annotations related to this gene include calcium ion binding and phosphoric diester hydrolase activity. An important paralog of this gene is PLCB3.

CAS Number

9007-83-4

Product Name Alternative

PLCB2; 1-phosphatidylinositol 4; 5-bisphosphate phosphodiesterase beta-2; Phosphoinositide phospholipase C-beta-2; Phospholipase C-beta-2; PLC-beta-2

Gene ID

5330

Accession Number

Q00722

Reactivity

Human, Mouse, Rat

Immunogen

Synthesized peptide derived from the Internal region of human PLC β2

Clonality

Polyclonal

Tag

1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2

Applications

WB, IHC

Purification Method

The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.

Concentration

1 mg/ml

Molecular Weight

150kD

Precautions

The product listed herein is for research use only and is not intended for use in human or clinical diagnosis. Suggested applications of our products are not recommendations to use our products in violation of any patent or as a license. We cannot be responsible for patent infringements or other violations that may occur with the use of this product.

Shipping Conditions

Gel pack with blue ice.

Storage Conditions

Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.

Notes

PLC β2 Polyclonal Antibody detects endogenous levels of PLC β2 protein.

Observed Molecular Weight

150

Formulation

Liquid solution

Buffer pH

Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.

Applications Notes

Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: WB 1:500-2000; IHC 1:50-300